Ofloxacin and Para drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ofloxacin (ofloxacin) and Para (para - aminobenzoic acid (paba)). Common drug interactions include drug-induced liver injury among females and multiple-drug resistance among males.

The phase IV clinical study analyzes what interactions people have when they take Ofloxacin and Para. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Ofloxacin?

Ofloxacin has active ingredients of ofloxacin. It is often used in urinary tract infection. eHealthMe is studying from 9,372 Ofloxacin users. Check the latest studies of Ofloxacin.

What is Para?

Para has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 2,194 Para users. Check the latest studies of Para.

On Jul, 15, 2026

40 people who take Ofloxacin and Para together, and have interactions are studied.

What are the common drug interactions of Ofloxacin and Para, by gender? *:

female:

Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Hepatosplenomegaly (enlargement of both the liver and the spleen)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Pallor
Abdominal distension
Neuropathy peripheral (surface nerve damage)
Respiratory failure (inadequate gas exchange by the respiratory system)
Bacterial infection
Capillary disorder (capillary disease)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

male:

Multiple-drug resistance
Pathogen resistance
Disease recurrence
Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
Drug resistance (reduction in effectiveness of a drug)

What are the common drug interactions of Ofloxacin and Para, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Alanine aminotransferase increased
Anaemia (lack of blood)
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hepatosplenomegaly (enlargement of both the liver and the spleen)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Pallor
Abdominal distension
Drug resistance (reduction in effectiveness of a drug)
Ataxia (loss of full control of bodily movements)

10-19:

Drug resistance (reduction in effectiveness of a drug)
Anaemia (lack of blood)
Neuropathy peripheral (surface nerve damage)
Drug ineffective
Leukopenia (less number of white blood cells in blood)
Blood thyroid stimulating hormone increased
Hypoaesthesia (reduced sense of touch or sensation)
Multiple-drug resistance
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Respiratory failure (inadequate gas exchange by the respiratory system)

20-29:

Drug resistance (reduction in effectiveness of a drug)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Pathogen resistance

30-39:

Drug ineffective
Anaemia (lack of blood)
Bacterial infection
Capillary disorder (capillary disease)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hypertensive crisis
Nephropathy toxic (damage to kidney due to toxins)
Pulmonary haemorrhage (acute bleeding from the lung)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

40-49:

Multiple-drug resistance
Arthralgia (joint pain)

50-59:

Drug resistance (reduction in effectiveness of a drug)

60+:

Delirium (wild excitement)
Diarrhoea
Dysarthria (speech disorder)
Hallucination, visual (seeing things that aren't there)
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Sleep disorder
Social avoidant behaviour (avoiding social connection a personality disorder)
Unresponsive to stimuli

What are the existing conditions these people have? *

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 27 people, 67.50%
Pulmonary Tuberculosis (lungs tuberculosis): 10 people, 25.00%
Meningitis Tuberculous (a bacterial infection of the membranes covering the brain and spinal cord (meninges)): 4 people, 10.00%
Disseminated Tuberculosis: 2 people, 5.00%
Delirium (wild excitement): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ofloxacin and Para?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously